Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Address
1 BRIDGE PLAZA, SUITE 275
FORT LEE, NJ 07024
Founded
2020
Number of Employees
13
Website
http://nuvectis.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)